Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Curr Alzheimer Res. 2020;17(4):324–328. doi: 10.2174/1567205017666200522204722

Fig. (1). Intranasal dantrolene maximizes CNS therapeutics but minimizes peripheral side effects.

Fig. (1).

The increased dantrolene concentrations in CNS after intranasal administration yield effective therapeutic effects with a relatively lower dose and lower peripheral side effects.